Article Sidebar

PDF (Tiếng Việt)
Published: 2022-03-01
Abstract Views: 268
Views PDF (Tiếng Việt): 500
DOI: https://doi.org/10.52852/tcncyh.v151i3.628
Issue
Vol. 151 No. 3 (2022)
Section
Các bài báo
How to Cite
Vinh, N. A. ., & Hoà, P. H. . (2022). Cut-off point value of serum NT-ProBNP in diagnosis of heart failure in children. Journal of Medical Research, 151(3), 153-161. https://doi.org/10.52852/tcncyh.v151i3.628

Cut-off point value of serum NT-ProBNP in diagnosis of heart failure in children

Ngo Anh Vinh, Pham Huu Hoa

Main Article Content

Abstract

 This study aimed to determine the optimal cut-off point of serum NT-ProBNP concentrations in
the diagnosis of heart failure in children. Serum NT-ProBNP concentrations were measured in 136
children who had heart failure and 272 healthy children from Vietnam National Children’s Hospital.
The age range of all children were from 1 month to 15 years. The NT-ProBNP concentrations of
the heart failure group were significantly higher than those of the healthy group (p < 0.001). The
diagnostic cut-off concentration was 314.5 pg/ml with a sensitivity of 88.2%, specificity of 66.7%,
and an area under the ROC curve of 0.81. The cut-off point of serum NT-ProBNP concentration
of 314.5 pg/ml was can serve as a diagnostic tool for heart failure among children in this study.

Article Details

Keywords

NT-ProBNP, cut-off point, heart failure, children

References

1. Massin MM, Astadicko I and Dessy H. Epidemiology of heart failure in a tertiary pediatric center. Clinical Cardiology. 2008;31(8): 388-391.
2. Rossano JW, Kim JJ, Decker JA, et al. Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: a population-based study. Journal of Cardiac Failure. 2012;18(6):459-470.
3. McKie PM, Burnett JC. NT-proBNP: The Gold Standard Biomarker in Heart Failure. Journal of the American College of Cardiology. 2016;68(22):2437-2439.
4. Huang YT, Tseng YT, Chu T W et al. N-terminal pro b-type natriuretic peptide (NT-pro-BNP) - based score can predict in-hospital mortality in patients with heart failure. Scientific Reports. 2016;6:29590.
5. Isah IA, Sadoh WE, Iduoriyekemwen NJ. Usefulness of amino terminal pro-B-type natriuretic peptide in evaluating children with cardiac failure. Cardiovascular Diagnosis and Therapy. 2017;7(4):380-388.
6. Hauser JA, Demyanets S, Rusai K, et al. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure. Heart Br Card Soc. 2016;102(20):1633-1639.
7. Hyun SK and Choi HJ. N-terminal pro-B-type natriuretic peptide levels in children: comparison in cardiac and non-cardiac diseases. Cardiology in the Young. 2020;30(4):500-504.
8. Ross RD. The Ross classification for heart failure in children after 25 years: a review and an age-stratified revision. Pediatr Cardiol. 2012;33(8):1295-1300.
9. Jayaprasad N. Heart Failure in Children. Heart Views Off J Gulf Heart Assoc. 2016;17(3):92-99.
10. Lin CW, Zeng XL, Zhang JF, et al. Determining the optimal cut-off values of plasma N-terminal pro-B-type natriuretic peptide levels for the diagnosis of heart failure in children of age up to 14 years. Journal of Cardiac Failure. 2014;20(3):168-173.
11. Sugimoto M, Manabe H, Nakau K, et al. The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. Correlation with the heart failure score and comparison with B-type natriuretic peptide. Circulation Journal Official Journal of the Japanese Circulation Society. 2010;74(5):998-1005.
12. Elsharawy S, Hassan B, Morsy S, et al. Diagnostic value of N-terminal pro-brain natriuretic peptide levels in pediatric patients with ventricular septal defect. Egyptian Heart Journal. 2012;64(4):241-246.